Does LUTETIUM OXODOTREOTIDE LU-177 Cause Hepatic function abnormal? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hepatic function abnormal have been filed in association with LUTETIUM OXODOTREOTIDE LU-177 (Lutathera). This represents 0.3% of all adverse event reports for LUTETIUM OXODOTREOTIDE LU-177.
16
Reports of Hepatic function abnormal with LUTETIUM OXODOTREOTIDE LU-177
0.3%
of all LUTETIUM OXODOTREOTIDE LU-177 reports
5
Deaths
6
Hospitalizations
How Dangerous Is Hepatic function abnormal From LUTETIUM OXODOTREOTIDE LU-177?
Of the 16 reports, 5 (31.3%) resulted in death, 6 (37.5%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUTETIUM OXODOTREOTIDE LU-177. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does LUTETIUM OXODOTREOTIDE LU-177 Cause?
Ill-defined disorder (1,538)
General physical health deterioration (906)
Death (431)
Malignant neoplasm progression (338)
Platelet count decreased (220)
Nausea (214)
Covid-19 (193)
Fatigue (185)
Diarrhoea (169)
Disease progression (169)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which LUTETIUM OXODOTREOTIDE LU-177 Alternatives Have Lower Hepatic function abnormal Risk?
LUTETIUM OXODOTREOTIDE LU-177 vs LUTROPIN ALFA
LUTETIUM OXODOTREOTIDE LU-177 vs LYMECYCLINE
LUTETIUM OXODOTREOTIDE LU-177 vs LYRICA
LUTETIUM OXODOTREOTIDE LU-177 vs LYSERGIDE
LUTETIUM OXODOTREOTIDE LU-177 vs MABTHERA